Three-dimensional analysis of right ventricular shape and function in pulmonary hypertension

Pulmonary Circulation

Volumn 2, Issue 1, 2012, Pages 34-40

  Leary, Peter J ^a   Kurtz, Christopher E ^b   Hough, Catherine L ^a   Waiss, Mary Pierre ^c   Ralph, David D ^a   Sheehan, Florence H ^b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

^c Ventripoint Inc   (United States)

Author keywords

3D echocardiography; Pulmonary hypertension; Right ventricle

Indexed keywords

EID: 84871233814     PISSN: 20458932     EISSN: 20458940     Source Type: Journal    
DOI: 10.4103/2045-8932.94828     Document Type: Article

References (31)

1. Gomberg-Maitland M, Dufton C, Oudiz RJ, Benza RL. Compelling Evidence of Long-Term Outcomes in Pulmonary Arterial Hypertension? J Am Coll Cardiol 2011;57:1053-61.
2. D’Alonzo GE, Barst RJ, Ayres SM, Bergofsky EH, Brundage BH, Detre KM, et al. Survival in patients with primary pulmonary hypertension. Results from a national prospective registry. Ann Intern Med 1991;115:343-9.
3. Sheehan F, Redington A. The right ventricle: Anatomy, physiology and clinical imaging. Heart 2008;94:1510-5.
4. van Wolferen SA, van de Veerdonk MC, Mauritz GJ, Jacobs W, Marcus JT, Marques KMJ, et al. Clinically Significant Change in Stroke Volume in Pulmonary Hypertension. Chest 2011;139:1003-9.
5. van Wolferen SA, Marcus JT, Boonstra A, Marques KM, Bronzwaer JG, Spreeuwenberg MD, et al. Prognostic value of right ventricular mass, volume, and function in idiopathic pulmonary arterial hypertension. Eur Heart J 2007;28:1250-7.
6. Mauritz GJ, Kind T, Marcus JT, Bogaard HJ, van de Veerdonk M, Postmus PE, et al. Progressive Changes in Right Ventricular Geometric Shortening and Long-term Survival in Pulmonary Arterial Hypertension. Chest 2011 Sep. 29;[Epub ahead of print]
7. Overbeek MJ, Lankhaar JW, Westerhof N, Voskuyl AE, Boonstra A, Bronzwaer JGF, et al. Right ventricular contractility in systemic sclerosisassociated and idiopathic pulmonary arterial hypertension. Eur Respir J 2008;31:1160-6.
8. Ghio S, Pazzano AS, Klersy C, Scelsi L, Raineri C, Camporotondo R, et al. Clinical and Prognostic Relevance of Echocardiographic Evaluation of Right Ventricular Geometry in Patients With Idiopathic Pulmonary Arterial Hypertension. Am J Cardiol 2011;107:628-32.
9. Amaki M, Nakatani S, Kanzaki H, Kyotani S, Nakanishi N, Shigemasa C, et al. Usefulness of three-dimensional echocardiography in assessing right ventricular function in patients with primary pulmonary hypertension. Hypertens Res 2009;32:419-22.
10. Jenkins C, Leano R, Chan J, Marwick TH. Reconstructed versus real-time 3-dimensional echocardiography: Comparison with magnetic resonance imaging. J Am Soc Echocardiogr. 2007;20:862-8.
11. Kawut SM, Lima JA, Barr RG, Chahal H, Jain A, Tandri H, et al. Sex and Race Differences in Right Ventricular Structure and Function: The Multi-Ethnic Study of Atherosclerosis-Right Ventricle Study. Circulation 2011;123: 2542-51.
12. Kawut S, Barr R, Lima J, Johnson C, Kizer J, Tandri H, et al. Right Ventricular Morphology and Function and Long-Term Outcomes: The MESA-Right Ventricle Study. Am Thorac Soc Abstract 183; 2011:A4991
13. Kawut SM, Barr RG, Johnson WC, Chahal H, Tandri H, Jain A, et al. Matrix metalloproteinase-9 and plasminogen activator inhibitor-1 are associated with right ventricular structure and function: The MESA-RV Study. Biomarkers 2010;15:731-8.
14. Salgo IS, Tsang W, Ackerman W, Ahmad H, Chandra S, Cardinale M, et al. Geometric Assessment of Regional Left Ventricular Remodeling by Three-Dimensional Echocardiographic Shape Analysis Correlates with Left Ventricular Function. J Am Soc Echocardiogr 2012;25:80-8.
15. Sheehan FH, Ge S, Vick GW, Urnes K, Kerwin WS, Bolson EL, et al. Threedimensional shape analysis of right ventricular remodeling in repaired tetralogy of Fallot. Am J Cardiol 2008;101:107-13.
16. Hubka M, Bolson EL, McDonald JA, Martin RW, Munt B, Sheehan FH. Three-dimensional echocardiographic measurement of left and right ventricular mass and volume: In vitro validation. Int J Cardiovasc Imaging 2002;18:111-8.
17. Mancini GJ, DeBoe SF, Anselmo E, Simon SB, LeFree MT, Vogel RA. Quantitative regional curvature analysis: An application of shape determination for the assessment of segmental left ventricular function in man. Am Heart J 1987;113:326-34.
18. López-Candales A, Dohi K, Iliescu A, Peterson RC, Edelman K, Bazaz R. An abnormal right ventricular apical angle is indicative of global right ventricular impairment. Echocardiography 2006;23:361-8.
19. Morcos P, Vick GW III, Sahn DJ, Jerosch-Herold M, Shurman A, Sheehan FH. Correlation of right ventricular ejection fraction and tricuspid annular plane systolic excursion in tetralogy of Fallot by magnetic resonance imaging. Int J Cardiovasc Imaging 2008;25:263-70.
20. López-Candales A, Bazaz R, Edelman K, Gulyasy B. Apical Systolic Eccentricity Index: A Better Marker of Right Ventricular Compromise in Pulmonary Hypertension. Echocardiography 2010;27:534-8.
21. López-Candales A, Rajagopalan N, Kochar M, Gulyasy B, Edelman K. Systolic eccentricity index identifies right ventricular dysfunction in pulmonary hypertension. Int J Cardiol 2008;129:424-6.
22. Ghio S, Klersy C, Magrini G, D’Armini AM, Scelsi L, Raineri C, et al. Prognostic relevance of the echocardiographic assessment of right ventricular function in patients with idiopathic pulmonary arterial hypertension. Int J Cardiol 2010;140:272-8.
23. Sitbon O, Humbert M, Nunes H, Parent F, Garcia G, Hervé P, et al. Long-term intravenous epoprostenol infusion in primary pulmonary hypertension: Prognostic factors and survival. J Am Coll Cardiol 2002;40:780-8.
24. Forfia PR, Fisher MR, Mathai SC, Housten-Harris T, Hemnes AR, Borlaug BA, et al. Tricuspid annular displacement predicts survival in pulmonary hypertension. Am J Respir Crit Care Med 2006;174:1034-41.
25. Mathai SC, Sibley CT, Forfia PR, Mudd JO, Fisher MR, Tedford RJ, et al. Tricuspid Annular Plane Systolic Excursion Is a Robust Outcome Measure in Systemic Sclerosis-associated Pulmonary Arterial Hypertension. J Rheumatol 2011;38:2410-8.
26. Chung L, Liu J, Parsons L, Hassoun PM, McGoon M, Badesch DB, et al. Characterization of Connective Tissue Disease-Associated Pulmonary Arterial Hypertension From REVEAL: Identifying Systemic Sclerosis as a Unique Phenotype. Chest 2010;138:1383-94.
27. Simonneau G, Robbins IM, Beghetti M, Channick RN, Delcroix M, Denton CP, et al. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol 2009;54(1 Suppl):S43-54.
28. Kawut SM, Horn EM, Berekashvili KK, Garofano RP, Goldsmith RL, Widlitz AC, et al. New predictors of outcome in idiopathic pulmonary arterial hypertension. Am J Cardiol 2005;95:199-203.
29. Kjaergaard J, Petersen CL, Kjaer A, Schaadt BK, Oh JK, Hassager C. Evaluation of right ventricular volume and function by 2D and 3D echocardiography compared to MRI. Eur J Echocardiogr 2006;7:430-8.
30. Kaul S, Tei C, Hopkins JM, Shah PM. Assessment of right ventricular function using two-dimensional echocardiography. Am Heart J 1984;107:526-31.
31. Nath J, Demarco T, Hourigan L, Heidenreich PA, Foster E. Correlation between right ventricular indices and clinical improvement in epoprostenol treated pulmonary hypertension patients. Echocardiography 2005;22:374-9.